Earlier today I came across this post on the Future of Biopharma blog that highlighted an article on ClinicalTrialsToday that details the recent expansion of three new clinical development offices Covance has opened in Central and Eastern Europe and the Middle East.
The purpose of the new offices is to speed clinical trials and develop strategic relationships in those areas. The new offices will be located in Kiev, Ukraine; Bratislava, Slovakia; and Tel Aviv, Israel. Covance has been providing services already in these parts for quite some time, but now these locations will support staff and the CRO’s regional network of field-based clinical research associates.
Search This Blog
Blog Archive
-
▼
2009
(141)
-
▼
February
(16)
- February Edition of Partnerships with CROs LinkedI...
- Unethical Clinical Trial Outsourcing
- New regulations from the Indian government
- Raising alarms, study sees trials migrating abroad
- Is Outsourcing of Clinical Trials Faulty?
- How to rescue a clinical trial
- Pfizer Plans to Disclose Payments Made to Clinical...
- Quintiles opens up Phase I Unit in India
- Microdosing could be a win/win for pharma, CROs
- PPD Extends its Reach to Eastern and Central Europe
- NIH Awards University of Texas $1.8M in Research G...
- Covance Opens Offices in Ukraine, Slovakia and Israel
- Covance expands into Eastern Europe and Middle East
- India to Conduct 5% Global Clinical Trials by 2012
- Executives are on the Move in the Outsourcing Indu...
- PRA International expands into southwest Asia
-
▼
February
(16)
No comments:
Post a Comment